Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”
MIT spinoff Sample6 has raised $12.7 million to create a better system for detecting bacteria in food, writes Luke Timmerman for Forbes. “The company has developed a technology that can target specific bioparticles, light them up and do it without enriching the sample,” explains Timmerman.
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.
A portable device developed by MIT researchers uses programmable yeast to create drugs on demand, reports Jamie Ducharme for Boston Magazine. The device “could be a lifesaver for doctors working in vulnerable conditions, such as the battlefield, a remote village, or even an ambulance,” writes Ducharme.
Popular Science reporter Samantha Cole writes that MIT researchers have developed a laptop-sized, portable device that can produce biopharmaceuticals for doctors in remote locations. Cole explains that the device can “produce a single dose of treatment with a series of steps, using genetically engineered yeast cells as a mini 'factory' for a variety of customizable drugs.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a portable pharmacy that can manufacture biopharmaceuticals and modify treatments. “Instead of relying on a cocktail that already exists, you can reprogram the reactor on demand to customize the treatment,” says Prof. Timothy Lu.
In a Boston Globe article about increasing interest in bio-agriculture, Robert Weisman highlights a number of MIT spinoffs, including Grove Labs and Ginkgo Bioworks. Weisman highlights the aquaponics systems Grove Labs is developing “complete with LED lighting, for growing fruit, vegetables, and herbs at home,” and how Ginkgo Bioworks is producing a “roster of ‘bio-products’ that include organic pesticides.”
In this video, BBC World News reporter Adam Shaw learns about the stretchy, water-based hydrogel MIT researchers developed that could be used as a smart bandage to sense temperatures and deliver medication. “This is a new way to think about this interface between the human body and electronic devices,” explains Prof. Xuanhe Zhao.
In this video, Bloomberg News reporter Sam Grobart examines the new hydrogel developed by MIT researchers that can bend and twist without breaking, and could be used to deliver medicines and monitor our health. Grobart explains that the hydrogel “could be a building block of the medicine of the future.”
A team of MIT researchers has been selected as the winner of the Koch Institute research-grant pitch competition for their work on developing a diagnostic platform for early-stage leukemia, reports Amanda Hoover for Boston.com. Hoover explains that the diagnostic method would “single out individual cells during blood tests, highlighting those affected by leukemia.”
Huffington Post reporter Carolyn Gregoire writes that MIT spinoff Synlogic is working on reprogramming gut bacteria to act as a living therapeutic. “It’s become really clear that the bacteria living in us and on us affect our bodies in a variety of different ways — in ways that we never imagined,” explains Prof. Timothy Lu.
MIT researchers are developing a smart bandage that could monitor and help heal wounds, according to Reuters. Prof. Xuanhe Zhao explains that if sensors in the bandage detected “an abnormal increase in temperature, for example, it will send out a command. Then the controlled drug delivery system can deliver a specific drug to that specific location.”
Prof. Ioannis Yannas was inducted into the National Inventor’s Hall of Fame for his work with Dr. John Burke on regenerating human skin as a treatment for burn victims, writes Robby Berman for Slate. In a video accompanying the story, Yannas explains that his work was focused on “speeding up the rate of closing up these wounds.”
Huffington Post reporter Lila Shapiro speaks with Robert Desimone, director of the McGovern Institute, about the use of the CRISPR gene-editing technique to treat neurological diseases. “CRISPR’s impact is potentially across the board,” says Desimone. “It went from nothing just a few years ago to being a tool that’s in everyone’s toolbox.”
Dana Guth reports for Boston Magazine on a new bandage developed by Prof. Xuanhe Zhao that can deliver medication directly to a wound. “The bandage is filled with tiny pathways, so that drugs can flow through its gel-like material, providing relief for burns and other minor skin conditions,” writes Guth.